The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Open accessPublished version of a preprint
The DOI matches its Crossref record; 524 of the 524 references it cites were found in a registry or an index.
Abstract
Tumorigenesis is a complex and dynamic process involving cell-cell and cell-extracellular matrix (ECM) interactions that allow tumor cell growth, drug resistance and metastasis. This review provides an updated summary of the role played by the tumor microenvironment (TME) components and hypoxia in tumorigenesis, and highlight various ways through which tumor cells reprogram normal cells into phenotypes that are pro-tumorigenic, including cancer associated- fibroblasts, -macrophages and -endothelial cells. Tumor cells secrete numerous factors leading to the transformation of a previously anti-tumorigenic environment into a pro-tumorigenic environment. Once formed, solid tumors continue to interact with various stromal cells, including local and infiltrating fibroblasts, macrophages, mesenchymal stem cells, endothelial cells, pericytes, and secreted factors and the ECM within the tumor microenvironment (TME). The TME is key to tumorigenesis, drug response and treatment outcome. Importantly, stromal cells and secreted factors can initially be anti-tumorigenic, but over time promote tumorigenesis and induce therapy resistance. To counter hypoxia, increased angiogenesis leads to the formation of new vascular networks in order to actively promote and sustain tumor growth via the supply of oxygen and nutrients, whilst removing metabolic waste. Angiogenic vascular network formation aid in tumor cell metastatic dissemination. Successful tumor treatment and novel drug development require the identification and therapeutic targeting of pro-tumorigenic components of the TME including cancer-associated- fibroblasts (CAFs) and -macrophages (CAMs), hypoxia, blocking ECM-receptor interactions, in addition to the targeting of tumor cells. The reprogramming of stromal cells and the immune response to be anti-tumorigenic is key to therapeutic success. Lastly, this review highlights potential TME- and hypoxia-centered therapies under investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which are essential for cell support, signaling, invasion, and metastasis [33]”
From The Synergistic Effect of Proanthocyanidin and HDAC Inhibitor Inhibit Breast Cancer Cell Growth and Promote Apoptosis (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, the interplay between the gut microbiome and the TME constitutes a critical regulatory axis that modulates tumor initiation, growth, metastatic dissemination, and responsiveness to treatment [11,43,45–47]”
From Phage therapy in oncology: opportunities for cancer prevention and treatment (2026) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–524 of 524
Kosaraju, R. S., Rennert, R. C., Maan, Z. N., Duscher, D., Barrera, J. A., Whittam, A. J., Januszyk, M., Rajadas, J., Rodrigues, M., & Gurtner, G. C. (2016) · Tissue Engineering Part A · doi:10.1089/ten.tea.2015.0277 · Cited by 86
Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes
KASHANI, K. B. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.021 · Cited by 85
Nilendu, P., Sarode, S. C., Jahagirdar, D., Tandon, I., Patil, S. V., Sarode, G. S., Pal, J. K., & Sharma, N. K. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0388-2 · Cited by 85
Regulation of Immunity in Breast Cancer
Edechi, C. A., Ikeogu, N. M., Uzonna, J. E., & Myal, Y. (2019) · Cancers · doi:10.3390/cancers11081080 · Cited by 85
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer
Reis, S. T., Pontes-Júnior, J., Antunes, A. A., de Sousa-Canavez, J. M., Abe, D. K., da Cruz, J. A. S., Dall’Oglio, M. F., Crippa, A., PASSEROTTI, C. C., Ribeiro‐Filho, L. A., et al. (2011) · Clinics · doi:10.1590/s1807-59322011000700004 · Cited by 85
Kraus, M., & Wolf, B. A. (1996) · Tumor Biology · doi:10.1159/000217977 · Cited by 84
Wang, L., Fu, Y. L., & Chu, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3532-1_8 · Cited by 83
Comparison of dermal substitutes in wound healing utilizing a nude mouse model.
Truong, A., Kowal-Vern, A., Latenser, B. A., Wiley, D. E., & Walter, R. J. (2005) · PubMed · Cited by 83
Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma
Xue, L., Mao, X., Ren, L., & Chu, X. (2017) · Cancer Medicine · doi:10.1002/cam4.1085 · Cited by 82
Sun, D.-Y., Wu, J.-Q., He, Z.-H., He, M.-F., & Sun, H.-B. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116791 · Cited by 82
Delivery of monocyte lineage cells in a biomimetic scaffold enhances tissue repair
Hu, M. S., Walmsley, G. G., Barnes, L. A., Weiskopf, K., Rennert, R. C., Duscher, D., Januszyk, M., Maan, Z. N., Hong, W. X., Cheung, A. T. M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.96260 · Cited by 81
Younan, G., Suber, F., Xing, W., Shi, T., Kunori, Y., Åbrink, M., Pejler, G., Schlenner, S. M., Rodewald, H.-R., Moore, F. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002803 · Cited by 79
Endosialin-Expressing Pericytes Promote Metastatic Dissemination
Viski, C., König, C., Kijewska, M., Mogler, C., Isacke, C. M., & Augustin, H. G. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0932 · Cited by 78
Li, G., Larregina, A. T., Domsic, R. T., Stolz, D. B., Medsger, T. A., Lafyatis, R., & Fuschiotti, P. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.11.037 · Cited by 78
Zhu, Z., Ding, J., Ma, Z., Iwashina, T., & Tredget, E. E. (2017) · Wound Repair and Regeneration · doi:10.1111/wrr.12532 · Cited by 78
Hormones of adipose tissue and their biologic role in lung cancer
Ntikoudi, E., Kiagia, M., Boura, P., & Syrigos, K. N. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.06.005 · Cited by 77
Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications
Jafari, R., Rahbarghazi, R., Ahmadi, M., Hassanpour, M., & Rezaie, J. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02662-9 · Cited by 77
Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures
Jensen, R. L. (2006) · Neurosurgical Focus · doi:10.3171/foc.2006.20.4.16 · Cited by 76
New insights into B cells as antigen presenting cells
Ghosh, D., Jiang, W., Mukhopadhyay, D., & Mellins, E. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.06.003 · Cited by 76
Lack of CXC Chemokine Receptor 3 Signaling Leads to Hypertrophic and Hypercellular Scarring
Yates, C. C., Krishna, P. D., Whaley, D., Bodnar, R. J., Turner, T., & Wells, A. H. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090564 · Cited by 76
Caveolin-1 Expression Level in Cancer Associated Fibroblasts Predicts Outcome in Gastric Cancer
Zhao, X., He, Y., Gao, J., Fan, L., Li, Z., Yang, G., & Chen, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059102 · Cited by 75
Decazes, P., & Bohn, P. (2020) · Cancers · doi:10.3390/cancers12020371 · Cited by 75
A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance
Huelsken, J., & Hanahan, D. (2018) · Cell · doi:10.1016/j.cell.2018.01.028 · Cited by 74
T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword
Vlachonikola, E., Σταματόπουλος, Κ., & Chatzidimitriou, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612244 · Cited by 74
Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer
Grywalska, E., Pasiarski, M., Góźdź, S., & Roliński, J. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s150817 · Cited by 73
Bi-Directional Signaling: Extracellular Matrix and Integrin Regulation of Breast Tumor Progression
Gehler, S., Ponik, S. M., Riching, K. M., & Keely, P. J. (2013) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.2013006647 · Cited by 73
The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
Wu, Y., Zhang, C., Jiang, K., Werner, J., Bazhin, A. V., & D’Haese, J. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.621937 · Cited by 71
Chemokine Involvement in Fetal and Adult Wound Healing
Balaji, S., Watson, C. L., Ranjan, R., King, A., Bollyky, P. L., & Keswani, S. G. (2014) · Advances in Wound Care · doi:10.1089/wound.2014.0564 · Cited by 70
Kuroda, H., Jamiyan, T., Yamaguchi, R., Kakumoto, A., Abe, A., Harada, O., & Masunaga, A. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02652-3 · Cited by 69
Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells
Chong, A. S., Markham, P. N., Gebel, H. M., Bines, S. D., & Coon, J. S. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01754414 · Cited by 69
Dzobo, K., & Dandara, C. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0023 · Cited by 68
Self-citationLymphatic Vessels in Tumor Dissemination versus Immunotherapy
Vaahtomeri, K., & Alitalo, K. K. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0156 · Cited by 68
Assessment of cell viability in a three-dimensional enzymatically cross-linked collagen scaffold
Garcia, Y., Collighan, R. J., Griffin, M., & Pandit, A. S. (2007) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-007-3091-9 · Cited by 67
Cross‐talk between IL‐6 and TGF‐β signaling in hepatoma cells
Yamamoto, T., Matsuda, T., Muraguchi, A., Miyazono, K., & Kawabata, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02258-x · Cited by 66
Kubow, K. E., Klotzsch, E., Smith, M. L., Gourdon, D., Little, W. C., & Vogel, V. (2009) · Integrative Biology · doi:10.1039/b914996a · Cited by 66
Sha, M., Jeong, S., Qiu, B., Tong, Y., Xia, L., Xu, N., Zhang, J., & Xia, Q. (2018) · Cancer Medicine · doi:10.1002/cam4.1704 · Cited by 65
Dzobo, K. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0019 · Cited by 63
Self-citationExosomes as diagnostic biomarkers in cancer
Kim, J., Kim, E., & Lee, M. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-018-0014-4 · Cited by 63
CD4+CD25hiCD127low Regulatory T Cells Are Increased in Oral Squamous Cell Carcinoma Patients
Lim, K. P., Chun, N. A. L., Ismail, S. M., Abraham, M. T., Yusoff, M. N., Zain, R. B., Ngeow, W. C., Ponniah, S., & Cheong, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103975 · Cited by 63
Sachinidis, A., Locher, R., Hoppe, J., & Vetter, W. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81447-v · Cited by 63
Prete, A., Lo, A. S., Sadow, P. M., Bhasin, S. S., Antonello, Z. A., Vodopivec, D. M., Ullas, S., Sims, J. N., Clohessy, J. G., Dvořàk, A. M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0693 · Cited by 63
Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin
Gao, Y., Chen, X., He, Q. W., Gimple, R. C., Liao, Y., Wang, L., Wu, R., Xie, Q., Rich, J. N., Shen, K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005950117 · Cited by 62
Characterization of T cell receptors on resident murine dendritic epidermal T cells
Steiner, G., Koning, F., Elbe, A., Tschachler, E., Yokoyama, W. M., Shevach, E. M., And, G. S., & Coligan, J. E. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180904 · Cited by 62
Biological therapies for the treatment of cutaneous wounds: Phase III and launched therapies
Rennert, R. C., Rodrigues, M., Wong, V. W., Duscher, D., Hu, M., Maan, Z., Sorkin, M., Gurtner, G. C., & Longaker, M. T. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.842972 · Cited by 62
Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer
Schmidt, E. V. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-018-0714-9 · Cited by 61
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
Nair, V. S., Saleh, R., Toor, S. M., Cyprian, F. S., & Elkord, E. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02842-y · Cited by 60
Rennert, R. C., Januszyk, M., Sorkin, M., Rodrigues, M., Maan, Z. N., Duscher, D., Whittam, A. J., Kosaraju, R., Chung, M. T., Paik, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11945 · Cited by 60
Expression of cancer-associated fibroblast markers in advanced colorectal cancer
Nishishita, R., Morohashi, S., Seino, H., Wu, Y., Yoshizawa, T., Haga, T., Saito, K., Hakamada, K., Fukuda, S., & Kijima, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8097 · Cited by 59
Dzobo, K., Turnley, T., Wishart, A. L., Rowe, A., Kallmeyer, K., van Vollenstee, F. A., Thomford, N. E., Dandara, C., Chopera, D., Pepper, M. S., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081259 · Cited by 59
Self-citationSaggar, J. K., & Tannock, I. F. (2014) · International Journal of Cancer · doi:10.1002/ijc.28595 · Cited by 58
Xue, X., Lu, Z., Tang, D., Yao, J. J., An, Y., Wu, J., Li, Q., Gao, W., Xu, Z., Qian, Z., et al. (2011) · Pancreas · doi:10.1097/mpa.0b013e318217945e · Cited by 58
Chemokines and their receptors as biomarkers in esophageal cancer
Goto, M., & Liu, M. (2019) · Esophagus · doi:10.1007/s10388-019-00706-8 · Cited by 57
Kim, S., Im, G., Jeong, G., Baik, S., Hyun, J., Kim, Y., Pang, C., Jang, Y. C., & Bhang, S. H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120954 · Cited by 55
Kim, T.-H., Jeon, W., Ji, Y., Park, E. J., Yoon, D. S., Lee, N., Park, S., Mandakhbayar, N., Lee, J., Lee, H., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120948 · Cited by 55
du Souich, P., & Fradette, C. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.586630 · Cited by 54
B Cells Promote Pancreatic Tumorigenesis
Roghanian, A., Fraser, C., Kleyman, M., & Chen, J. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0100 · Cited by 54
Shi, J., Feng, J., Xie, J., Mei, Z., Shi, T., Wang, S., Du, Y., Yang, G. S., Wu, Y., Cheng, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09020-8 · Cited by 53
Mast cells play role in wound healing through the ZnT2/GPR39/IL-6 axis
Nishida, K., Hasegawa, A., Yamasaki, S., Uchida, R., Ohashi, W., Kurashima, Y., Kunisawa, J., Kimura, S., Iwanaga, T., Watarai, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47132-5 · Cited by 53
Corsiero, E., Delvecchio, F. R., Bombardieri, M., & Pitzalis, C. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.01.004 · Cited by 51
B-Cell-Based Immunotherapy: A Promising New Alternative
Gupta, S. L., Khan, N., Basu, S., & Soni, V. (2022) · Vaccines · doi:10.3390/vaccines10060879 · Cited by 51
Interaction of Stellate Cells with Pancreatic Carcinoma Cells
Habisch, H., Zhou, S., Siech, M., & Bachem, M. G. (2010) · Cancers · doi:10.3390/cancers2031661 · Cited by 51
Progenitor Cell Dysfunctions Underlie Some Diabetic Complications
Rodrigues, M., Wong, V., Rennert, R. C., Davis, C. R., Longaker, M. T., & Gurtner, G. C. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.05.003 · Cited by 51
Papait, A., Stefani, F. R., Cargnoni, A., Magatti, M., Parolini, O., & Silini, A. R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00447 · Cited by 50
Long-term in-vivo tumorigenic assessment of human culture-expanded adipose stromal/stem cells
MacIsaac, Z. M., Shang, H., Agrawal, H., Yang, N., Parker, A. M., & Katz, A. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.12.002 · Cited by 50
The contribution of melanocytes to pathological scar formation during wound healing.
Gao, F.-L., Jin, R., Zhang, L., & Zhang, Y. (2013) · Europe PMC (PubMed Central) · Cited by 50
Yang, Z., Ni, W., Cui, C., Fang, L., & Xuan, Y. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.02.012 · Cited by 49
Differential Evaluation of Excisional Non-occluded Wound Healing in db/db Mice
Tkalčević, V. I., Čužić, S., Parnham, M. J., Pašalić, I., & Brajša, K. (2009) · Toxicologic Pathology · doi:10.1177/0192623308329280 · Cited by 49
Ronca, R., Van Ginderachter, J. A., & Turtoi, A. (2018) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000420 · Cited by 48
Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance
Bui, T. M., Yalom, L. K., & Sumagin, R. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1954162 · Cited by 47
The Dialogue Between Endothelial Cells and Monocytes/Macrophages in Vascular Syndromes
Martin, J., Collot-Teixeira, S., McGregor, L., & McGregor, J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780831248 · Cited by 47
Tentori, L., Dorio, A., Muzi, A., Lacal, P., Ruffini, F., Navarra, P., & Graziani, G. (2008) · Oncology Reports · doi:10.3892/or.19.4.1039 · Cited by 43
Uen, Y., Wang, J.-W., Wang, C., Jhang, Y., Chung, J.-Y., Tseng, T., Sheu, M., & Lee, S. (2018) · Oncotarget · doi:10.18632/oncotarget.25589 · Cited by 43
Wong, V. W., Garg, R. K., Sorkin, M., Rustad, K. C., Akaishi, S., Levi, K., Nelson, E. R., Tran, M., Rennert, R., Liu, W., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000219 · Cited by 42
Yamaguchi, Y., Okazaki, Y., Seta, N., Satoh, T., Takahashi, K., Ikezawa, Z., & Kuwana, M. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3180 · Cited by 42
Hajj, C., Russell, J., Hart, C. P., Goodman, K. A., Lowery, M. A., Haimovitz‐Friedman, A., Deasy, J. O., & Humm, J. L. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.06.010 · Cited by 41
The Role of Focal Adhesion Kinase in Keratinocyte Fibrogenic Gene Expression
Januszyk, M., Kwon, S. H., Wong, V., Padmanabhan, J., Maan, Z. N., Whittam, A. J., Major, M. R., & Gurtner, G. C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091915 · Cited by 41
Emerging roles of exosomal miRNAs in breast cancer drug resistance
Najminejad, H., Kalantar, S. M., Abdollahpour‐Alitappeh, M., Karimi, M. H., Seifalian, A. M., Gholipourmalekabadi, M., & Sheikhha, M. H. (2019) · IUBMB Life · doi:10.1002/iub.2116 · Cited by 40
Small Molecule Antagonists of Integrin Receptors
Perdih, A., & Dolenc, M. S. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791698558 · Cited by 40
Liu, K., Sun, B., Zhao, X., Wang, X., Li, Y., Qiu, Z., Liu, T., GU, Q., Dong, X., Zhang, Y., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2293 · Cited by 40
Mouse Mast Cell Proteases 4 and 5 Mediate Epidermal Injury through Disruption of Tight Junctions
Bankova, L. G., Lezcano, C., Pejler, G., Stevens, R. L., Murphy, G. F., Austen, K. F., & Gurish, M. F. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301794 · Cited by 39
Endothelial cells maintain neural stem cells quiescent in their niche
de Azevedo, P. O., Lousado, L., Paiva, A. E., Andreotti, J. P., Santos, G. S. P., Sena, I. F. G., Prazeres, P. H. D. M., Filev, R., Mintz, A., & Birbrair, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.059 · Cited by 38
Wound dressings containing bFGF-impregnated microspheres
Huang, S., Deng, T., Wu, H. P., Chen, F., & Jin, Y. J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040500435170 · Cited by 38
Genetic changes in tumour microenvironments
Campbell, I., Qiu, W., & Haviv, I. (2011) · The Journal of Pathology · doi:10.1002/path.2842 · Cited by 37
Wang, S., Yang, H., Tang, Z., Long, G., & Huang, W. (2015) · Stem Cells International · doi:10.1155/2016/3269267 · Cited by 37
Min, A., Zhu, C., Peng, S., Shuai, C., Sun, L., Han, Y., Qian, Y., Gao, S., & Su, T. (2016) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21777 · Cited by 35
Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma
Tang, X. X., Shimada, H., & Ikegaki, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650427 · Cited by 35
PD1 makes waves in anticancer immunotherapy
Flemming, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3806 · Cited by 33
Mast Cells: An Unexpected Finding in the Modulation of Cutaneous Wound Repair by Charged Beads
Sasaki, A., Mueller, R. V., Gong, X., Sipe, R., Buck, D. C., & Hollinger, J. O. (2003) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000049451.38505.45 · Cited by 32
Yang, F., Zhang, S., Meng, Q., Zhou, F., Pan, B., Liu, F., & Yu, Y. (2021) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.102001 · Cited by 29
Yu, X., Zhang, L., Chaudhry, A., Rapaport, A. S., & Ouyang, W. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.6mr0320-234r · Cited by 29
Exosomes in esophageal cancer: A review on tumorigenesis, diagnosis and therapeutic potential
Su, L., Chang, X., Zhou, H., Hou, L., & Xue, X. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i8.908 · Cited by 28
Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?
Tolle, F., Umansky, V., Utikal, J. S., Kreis, S., & Bréchard, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136744 · Cited by 28
The Abnormal Architecture of Healed Diabetic Ulcers Is the Result of FAK Degradation by Calpain 1
Liu, W. R., Ma, K., Kwon, S. H., Garg, R. K., Patta, Y. R., 藤原敏宏, & Gurtner, G. C. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.11.039 · Cited by 28
alpha 3 beta 1 integrin-controlled Smad7 regulates reepithelialization during wound healing in mice
Reynolds, L., Conti, F., Silva, R., Robinson, S., Iyer, V, Rudling, R. J., Cross, B., Nye, E. L., Hart, I., DiPersio, C. M., et al. (2008) · UCL Discovery (University College London) · Cited by 28
Serini, G., Bochaton-piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L., & Gabbiani, G. (1998) · Cited by 28
Tschachler, E., Steiner, G., Yamada, H., Elbe, A., Wolff, K. S., & Stingl, G. (1989) · Journal of Investigative Dermatology · doi:10.1016/0022-202x(89)90197-8 · Cited by 27
Dzobo, K., & Dandara, C. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0042 · Cited by 25
Self-citationDzobo, K. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0049 · Cited by 25
Self-citationOhnishi, Y., Inoue, H., FURUKAWA, M., Kakudo, K., & Nozaki, M. (2011) · Oncology Reports · doi:10.3892/or.2011.1616 · Cited by 25
Feedback regulation of the α2(1) collagen gene via the Mek–Erk signaling pathway
Dzobo, K., Leaner, V. D., & Parker, M. I. (2011) · IUBMB Life · doi:10.1002/iub.568 · Cited by 24
Self-citationTargeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro
Elechalawar, C. K., Hossen, M. N., Shankarappa, P. S., Peer, C. J., Figg, W. D., Robertson, J. D., Bhattacharya, R., & Mukherjee, P. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s234112 · Cited by 24
Ebrahimi-Nik, H., Corwin, W. L., Shcheglova, T. V., Mohapatra, A. D., Măndoiu, I., & Srivastava, P. K. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2202-4 · Cited by 24
Huang, C., Wang, H., Liao, W., Han, F., Li, Y., Chen, S.-W., & Lao, X. (2017) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000166 · Cited by 23
Atat, O. E., Antonios, D., Hilal, G., Hokayem, N. E., Ghoch, J. A., Hashim, H., Serhal, R., Hebbo, C., Moussa, M., & Alaaeddine, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162332 · Cited by 23
Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools
Volovitz, I., Melzer, S., Amar, S., Bocsi, J., Bloch, M., Efroni, S., Ram, Z., & Tárnok, A. (2016) · International Reviews of Immunology · doi:10.3109/08830185.2015.1096935 · Cited by 21
Absence of feedback regulation in the synthesis of COL1A1
Dzobo, K., Leaner, V. D., & Parker, M. I. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.03.006 · Cited by 21
Self-citationTumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesis
Williams, J., Camarda, R., Malkov, S., Zimmerman, L. J., Manning, S., Aran, D., Beardsley, A. R., de Mark, D. V., Nakagawa, R. M., Chen, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62486-3 · Cited by 21
P-glycoprotein-mediated multidrug resistance and cytotoxic effector cells.
Savaş, B., Cole, S. P. C., Akoğlu, T., & Pross, H. F. (1992) · PubMed · Cited by 19
The detached pericyte hypothesis: A novel explanation for many puzzling aspects of tumorigenesis
Baker, S. G. (2018) · Organisms. Journal of Biological Sciences · doi:10.13133/2532-5876_3.10 · Cited by 15
Pieterse, Z., Sinha, D., & Kaur, P. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16908-4_5 · Cited by 14
Chen, V. E., Greenberger, B. A., Taylor, J. M., Edelman, M. J., & Lü, B. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.03.022 · Cited by 14
T-Regulatory Cells in Health and Disease
Elkord, E., & Nair, V. S. (2018) · Journal of Immunology Research · doi:10.1155/2018/5025238 · Cited by 13
Role of P-glycoprotein in Human Natural Killer-Like Cell Line-Mediated Cytotoxicity
Takahashi, M., Misawa, Y., Watanabe, N., Kawanishi, T., Tanaka, H., Shigenobu, K., & Kobayashi, Y. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4696 · Cited by 12
Dzobo, K. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0069 · Cited by 9
Self-citationAthavale, S. M., Rangarajan, S. V., Dharamsi, L. M., Wentz, S. C., Phillips, S. E., McRackan, T. R., & Yarbrough, W. G. (2012) · Head & Neck · doi:10.1002/hed.22952 · Cited by 9
The Closure of a Large Chronic Abdominal Wound in a Neonate Utilizing a Biologic Dressing
Joncas, V., Prado, R., Ritchie, C. P., Kaufman, L. M., Schober-Flores, C., & Arbuckle, H. A. (2010) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000383212.95911.f5 · Cited by 9
Reconstructive surgeries after extensive burns in children.
Suchánek, I., Ríhová, H., Kaloudová, Y., & Máger, R. (2003) · PubMed · Cited by 9
Kovacic, J. C., Mercader Huber, N. I., Torres, M., Boehm, M., & Fuster, V. (n.d.) · doi:10.7892/boris.79620 · Cited by 9
Race Does Not Predict Melanocyte Heterogeneous Responses to Dermal Fibroblast-Derived Mediators
Sirimahachaiyakul, P., Sood, R. F., Muffley, L. A., Seaton, M. E., Lin, C.-T., Qiao, L., Armaly, J., Hocking, A. M., & Gibran, N. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139135 · Cited by 7
The Future of Tissue Engineering and Regenerative Medicine in Africa
Dzobo, K., Senthebane, D. A., Pillay, M., Ssemakalu, C. C., Mkhumbeni, N., & Motaung, K. S. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0375 · Cited by 6
Self-citationIntegration of the Human Dermal Mast Cell into the Organotypic Co-culture Skin Model
Kim, J., Guhl, S., Babina, M., Zuberbier, T., & Artuc, M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1173-8_6 · Cited by 5
Chen, L., Chen, Q., Hou, W., & He, L. (2017) · Parasitology Research · doi:10.1007/s00436-017-5381-6 · Cited by 5
Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesisPreprint
Williams, J. R., Camarda, R., Malkov, S., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/277939 · Cited by 4
Different roles of myofibroblasts in the tumorigenesis of nonsmall cell lung cancer
Huang, J., Li, Z., Ding, Z., Luo, Q., & Lu, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3862-8 · Cited by 2
Cited by
Unveiling the mechanisms and challenges of cancer drug resistance
Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01302-1 · Cited by 417
“…factors, extracellular vesicles (EVs), immune cells, etc. Tumor-associated rigid and condensed ECM affects the drug response by reducing drug transport and sequestering drugs through direct binding with it thus represents a significant mechanism of drug resistance in many solid tumors [18, 19].”
BackgroundThe Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis
Dzobo, K., & Dandara, C. (2023) · Biomimetics · doi:10.3390/biomimetics8020146 · Cited by 171
Self-citationDrug resistance and tumor immune microenvironment: An overview of current understandings (Review)
Liu, Y., Liang, J., Zhang, Y., & Guo, Q. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5684 · Cited by 107
Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
Flies, D. B., Langermann, S., Jensen, C., Karsdal, M. A., & Willumsen, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199513 · Cited by 88
Sandbhor, P., Palkar, P., Bhat, S., John, G., & Goda, J. S. (2024) · Nanoscale · doi:10.1039/d3nr06131k · Cited by 86
Metadata
- Authors
- Dzobo, K., Senthebane, D. A., & Dandara, C.
- Affiliations
- South African Medical Research Council (ZA)
- University of Cape Town (ZA)
- Corresponding author
- Dzobo, Kevin
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2023-01-06
- Volume
- 15
- Issue
- 2
- Pages
- 376
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC9856874
- OpenAlex
- W4313640373
- Cited by
- 146
- References
- 509
- Citations by year
- 2026: 33 · 2025: 26 · 2024: 51 · 2023: 36
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Open University of Cape Town (University of Cape Town) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor microenvironment, carcinogenesis, treatment resistance, hypoxia, cancer-associated fibroblasts, cancer-associated macrophages, tumor endothelial cells, tumor stroma, extracellular matrix, angiogenesis, metastasis, ECM-receptor interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.